IR Pharma company logo
  • Company overview
  • Technology - The drug development process at IRP, The Drug Evaluation Process, Model systems
  • Contact us
  • We always adopt a collaborative approach
    975 Cornforth Drive
    Kent Science Park
    Sittingbourne, Kent ME9 8PX
    T 01795 437426
    F 01795 423440
    E info@irpharma.co.uk
    National Heart & Lung Institute
    Sir Alexander Fleming Building
    Imperial College, London SW7 2AZ
    T 01795 437426
    F 01795 423440
    E info@irpharma.co.uk

    Working with IR Pharma

    At IR Pharma, we fully understand the difficulties associated with evaluating and developing new treatments and drugs and, when working with our clients on any project, no matter how routine and regardless of company size, we always adopt a collaborative approach.

    Self evidently, the initial step in working together involves understanding a potential clients needs and this process begins following an initial enquiry expressing interest in the services we provide.

    This will initiate a rapid response from our business management team (all have life science research backgrounds), who, without obligation, will make contact to establish an outline of your requirements. Naturally, we fully respect confidentiality, and even at this early stage, we are happy to accommodate and formalise arrangements through CDA.

    Once we have a reasonable outline of your needs, details will be forwarded to our scientific team for an initial assessment and comments on the investigational studies that would appear relevant.

    This information will be relayed back to you as a potential client with a view to more detailed follow-on discussion concerning the next steps and how we can assist in the development of your product.

    If you feel we, at IR Pharma, may be able to provide support and assistance with the pre-clinical assessment of your product please contact us via e-mail or telephone at the address below. We are confident we can make a positive impact on your discovery needs.